2010

  1. 1.Ateenyi-Agaba C, Franceschi S, Wabwire-Mangen F, Arslan A, Othieno E, Binta-Kahwa J, van Doorn LJ, Kleter B, Quint W, Weiderpass E. Human papillomavirus infection and squamous cell carcinoma of the conjunctiva. Br J Cancer 2010; 102: 262-267.

  2. 2.Banura C, Sandin S, van Doorn LJ, Quint W, Kleter B, Wabwire-Mangen F, Mbidde EK, Weiderpass E. Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: a prospective study in Uganda. Infect Agent Cancer 2010; 9: 7.

  3. 3.Boon ME. Het ABC van het Uitstrijkje. Leiden: Coulomb Press Leyden, 2010.

  4. 4.Bouwes Bavinck JN, Neale RE, Abeni D, Euvrard S, Green AC, Harwood CA, de Koning MN, Naldi L, Nindl I, Pawlita M, Pfister H, Proby CM, Quint WG, ter Schegget J, Waterboer T, Weissenborn S, Feltkamp MC; EPI-HPV-UV-CA group. Multicenter study of the association between betapapillomavirus infection and cutaneous squamous cell carcinoma. Cancer Res 2010; 70: 9777-9786.

  5. 5.Breijer JP. Op avontuur met Thil Boon. VAP Visie 2010; 10: 35-37.

  6. 6.Briët MC, Berger TH, van Ballegooijen M, Boon ME, Rebolj M. Effects of streamlining cervical cancer screening the Dutch way: consequences of changes in the Dutch KOPAC-based follow-up protocol and consensus-based limitation of equivocal cytology. Acta Cytol 2010; 54: 1095-1100.

 

  1. 7.Coseo S, Porras C, Hildesheim A, Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Gonzalez P, Wang SS, Sherman ME, Jimenez S, Solomon D, Bougelet C, van Doorn LJ, Quint W, Safaeian M; Costa Rica HPV Vaccine Trial (CVT) Group. Seroprevalence and correlates of HPV 16/18 seropositivity among young women in Costa Rica. Sex Transm Dis 2010; 37: 706-714.

 

  1. 8.Cubilla AL, Lloveras B, Alejo M, Clavero O, Chaux A, Kasamatsu E, Velazquez EF, Leczano C, Monfulleda N, Tous S, Alemany L, Klaustermeier J, Muñoz N, Quint W, de Sanjose S, Bosch FX. The basaloid cell is the best tissue marker for human papillomavirus in invasive penile squamous cell carcinoma: a study of 202 cases from Paraguay. Am J Surg Pathol 2010; 34: 104-114.

 

  1. 9.De Sanjose S, Quint WQ, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menéndez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andújar M, Castellsagué X, Sànchez GI, Nowakowski AM, Bornstein J, Muñoz N, Bosch FX; Retrospective international survey and HPV time trends study group. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 2010: 11: 1048-1056.

 

  1. 10.Iftner T, Eberle S, Iftner A, Holz B, Banik N, Quint W, Straube NA. Prevalence of low-risk and high-risk types of human papillomavirus and other risk factors for HPV infection in Germany within different age groups in women up to 30 years of age: an epidemiological observational study. J Med Virol 2010; 82: 1928-1939.

 

  1. 11.Klomp JM, Boon ME, Dorman MZ, van Haaften M, Heintz AP. Trends in inflammatory status of the vaginal flora as established in the Dutch national screening program for cervical cancer over the last decade. Acta Cytol 2010; 54: 43-49.

 

  1. 12.de Koning MN, ter Schegget J, Eekhof JA, Kamp M, Kleter B, Gussekloo J, Feltkamp MC, Bouwes Bavinck JN, Purdie KJ, Bunker CB, Proby CM, Meys R, Harwood CA, Quint WG. Evaluation of a novel broad-spectrum PCR-multiplex genotyping assay for identification of cutaneous wart-associated human papillomavirus types. J Clin Microbiol 2010; 48: 1706-1711.

 

  1. 13.Küsters-Vandevelde HV, van Leeuwen A, Verdijk MA, de Koning MN, Quint WQ, Melchers WJ, Ligtenberg MJ, Blokx WA. CDKN2A but not TP53 mutations nor HPV presence predict poor outcome in metastatic squamous cell carcinoma of the skin. Int J Cancer 2010; 126: 2123-2132.

 

  1. 14.Mallitt KA, O’Rourke P, Bouwes Bavinck JN, Abeni D, de Koning MN, Feltkamp MC, Green AC, Quint WQ, Pawlita M, Pfister H, Weissenborn S, Waterboer T, Neale RE, EPI-HPV-UV-CA Group. An analysis of clustering of betapapillomavirus antibodies. J Gen Virol 2010; 91: 2062-2067.

 

  1. 15.Mariani L, Monfulleda N, Alemany L, Vizza E, Marandino F, Vocaturo A, Benevolo M, Quirós B, Lloveras B, Klaustermeier JE, Quint W, de Sanjosé S, Bosch FX. Human Papilloma Virus prevalence and type-specific relative contribution in invasive cervical cancer specimens from Italy. BMC Cancer 2010; 4: 259-268.

 

  1. 16.Middag-Broekman JHFF, Boon ME. Schimmelinfecties van de Huid en de Nagel in de Eerstelijnsgeneeskunde. Derde editie. Leiden: Coulomb Press Leyden, 2010.

 

  1. 17.Odida M, de Sanjose S, Sandin S, Quiros B, Alemany L, Lloveras B, Quint W, Kleter B, Alejo M, van Doorn LJ, Weiderpass E. Comparison of human papillomavirus detection between freshly frozen tissue and paraffin embedded tissue of invasive cervical cancer. Infect Agent Cancer 2010; 16: 15.

 

  1. 18.Oh JK, Alemany L, Suh JI, Rha SH, Muñoz N, Bosch FX, Quint W, Lloveras B, Klaustermeier JE, de Sanjosé S, Shin HR. Type-specific human papillomavirus distribution in invasive cervical cancer in Korea, 1958-2004. Asian Pac J Cancer Prev 2010; 11: 993-1000.

 

  1. 19.Plasmeijer EI, Green AC, de Koning MN, O’Rourke P, Quint WQ, Feltkamp MC, Neale RE. Transmission of betapapillomaviruses between domestic partners in an Australian community. J Clin Virol 2010; 47: 216-218.

 

  1. 20.Plasmeijer EI, Neale RE, Buettner PG, de Koning MN, ter Schegget J, Quint WQ, Green AC, Feltkamp MC. Betapapillomavirus infection profiles in tissue sets from cutaneous squamous cell-carcinoma patients. Int J Cancer 2010; 126: 2614-2621.

 

  1. 21.Plasmeijer EI, Neale RE, O’Rourke P, Mallitt KA, de Koning MN, Quint W, Buettner PG, Pawlita M, Waterboer T, Green AC, Feltkamp MC. Lack of association between the presence and persistence of betapapillomavirus DNA in eyebrow hairs and betapapillomavirus L1 antibodies in serum. J Gen Virol 2010; 91: 2073-2079.

 

  1. 22.Porras C, Bennett C, Safaeian M, Coseo S, Rodríguez AC, González P, Hutchinson M, Jiménez S, Sherman ME, Wacholder S, Solomon D, van Doorn LJ, Bougelet C, Quint W, Schiffmann M, Herrero R, Hildesheim A; Costa Rica HPV Vaccine Trial (CVT) Group. Determinants of seropositivity among HPV-16/18 DNA positive young women. BMC Infect Dis 2010; 10: 238.

 

  1. 23.Quint KD, Bom RJ, Bruisten SM, van Doorn LJ, Nassir Hajipour N, Melchers WJ, de Vries HJ, Morre SA, Quint WQ. Comparison of three genotyping methods to identify Chlamydia trachomatis genotypes in positive men and women. Moll Cell Probes 2010; 24: 266-270.

 

  1. 24.Quint KD, de Koning MN, van Doorn LJ, Quint WG, Pirog EC. HPV genotyping and HPV16 variants analysis in glandular and squamous neoplastic lesions of the uterine cervix. Gynecol Oncol 2010; 117: 297-301.

 

  1. 25.Risse EK, Ouwerkerk-Noordam E, Meijer-Marres EM, Boon ME. Exploiting the residual of cervical thin layer brush samples through cytohistology in cases with invasive carcinoma with application of antibodies. Acta Cytol 2010; 54: 175-182.

 

  1. 26.Roeters AME, Boon ME, van Haaften M, Vernooij F, Bontekoe TjR, Heintz APM. Inflammatory events as detected in cervical smears and squamous intraepithelial lesions. Diagn Cytopathol 2010; 38: 85-93.

 

  1. 27.Safaeian M, Porras C, Schiffman M, Rodriguez AC, Wacholder S, Quint W, van Doorn LJ, Sherman ME, Xhenseval V, Herrero R, Hildesheim A; Costa Rican Vaccine Trial Group. Epidemiological study of anti-HPV16/18 seropositivity and subsequent risk of HPV16 and -18 infections. J Natl Cancer Inst 2010; 102: 1653-1662.

 

  1. 28.Safaeian M, Quint K, Schiffman M, Rodriguez AC, Wacholder S, Herrero R, Hildesheim A, Viscidi RP, Quint W, Burk RD. Chlamydia trachomatis and risk of prevalent and incident cervical premalignancy in a population-based cohort. J Natl Cancer Inst 2010; 102: 1794-1804.

 

  1. 29.Schmeink CE, Massuger LF, Lenselink CH, Quint WG, Melchers WJ, Bekkers RL. Effect of the menstrual cycle and hormonal contraceptives on HPV detection in young unscreened women. Obstet Gynecol 2010; 116: 67-75.

 

  1. 30.Tabora N, Melchers WJ, van Doorn LJ, Quint W, Ferrera A. Molecular variants of HPV type 16 E6 among Honduran women. Int J Gynecol Cancer 2010; 20: 323-328.

 

  1. 31.Wacholder S, Chen BE, Wilcox A, Macones G, Gonzalez P, Befano B, Hildesheim A, Rodríguez AC, Solomon D, Herrero R, Schiffman M; CVT group. Risk of miscarriage with bivalent vaccine against human papillomavirus (HPV) types 16 and 18: pooled analysis of two randomised controlled trials. BMJ 2010; 340: c712.

 

  1. 32.Wilkinson DE, Baylis SA, Padley D, Heath AB, Ferguson M, Pagliusi SR, Quint WG, Wheeler CM; Collaboratorive Study Group. Establishment of the 1st World Health Organization international standards for human papillomavirus type 16 DNA and type 18 DNA. Int J Cancer 2010; 126: 2969-2983.

 

 

 2011

  1. 1.Bax CJ, Quint KD, Peters RP, Ouburg S, Oostvogel PM, Mutsaers JA, Dörr PJ, Schmidt S, Jansen C, van Leeuwen AP, Quint WQ, Trimbos JB, Meijer CJ, Morré SA. Analysis of multiple-site and concurrent Chlamydia trachomatis serovar infections, and serovar tissue tropism for urogenital versus rectal specimens in male and female patients. Sex Transm Infect 2011; 87: 503-507.

 

  1. 2.de Bie RP, Schmeink CE, Bakkers JM, Snijders PJ, Quint WG, Massuger LF, Bekkers RL, Melchers WJ. The indicating FTA elute cartridge a solid sample carrier to detect high-risk HPV and high-grade cervical lesions. J Mol Diagn 2011; 13: 371-376.

 

  1. 3.Boon ME, Kok LP. BoonFix. Japanese Patent No. 4824684, 16 September 2011.

 

  1. 4.Boon ME, Ouwerkerk-Noordam E, Meijer-Marres EM, Bontekoe TjR. Switching from neural networks (PAPNET) to the Imager (Hologic) for computer-assisted screening. Acta Cytol 2011; 55: 163-166.

 

  1. 5.Chaturvedi AK, Katki HÁ, Hildesheim A, Rodríguez AC, Quint WG, Schiffman M, van Doorn LJ, Porras C, Wacholder S, Gonzalez P, Sherman ME, Herrero R; CVT Group. Human papillomavirus infection with multiple types: pattern of coinfection and risk of cervical disease. J Infect Dis 2011; 203: 910-920.

 

  1. 6.Coseo SE, Porras C, Dodd LE, Hildesheim A, Rodriguez AC, Schiffman M, Herrero R, Wacholder S, Gonzalez P, Sherman ME, Jimenez S, Solomon D, Bougelet C, van Doorn LJ, Quint W, Safaeian M; Costa Rica HPV Vaccine Trial (CVT) Group. Evaluation of the polyclonal ELISA HPV serology assay a biomarker for Human Papillomavirus exposure. Sex Transm Dis 2011; 38: 976-982.

 

  1. 7.Cubilla AL, Lloveras B, Alejo M, Clavero O, Chaux A, Kasamatsu E, Monfulleda N, Tous S, Alemany L, Klaustermeier J, Muñoz N, Quint W, de Sanjosé S, Bosch FX. Value of p16 (INK)4 (a) in the pathology of invasive penile squamous cell carcinomas: A report of 202 cases. Am J Surg Pathol 2011; 35: 253-261.

 

  1. 8.Dols JAM, Boon ME, Monachese M, Changalucha J, Butamanya N, Varriano S, Vihant O, Hullegie Y, van Tienen A, Hummelen R, Reid G. The impact of probiotic yogurt on HIV positive women in Tanzania. Int Dairy J 2011; 21: 575-577.

 

  1. 9.Dols JAM, Smit PW, Kort R, Reid G, Schuren FHJ, Tempelman H, Bontekoe TjR, Korporaal H, Boon ME. Microarray-based identification of clinically relevant vaginal bacteria in relation to bacterial vaginosis. Am J Obstet Gynecol 2011; 204: 305.e1-7.

 

  1. 10.Geraets DT, Lenselink CH, Bekkers RL, van Doorn LJ, Quint WG, Melchers WJ. Universal human papillomavirus genotyping by the digene HPV genotyping RH and LQ tests. J Clin Virol 2011; 50: 276-280.

 

  1. 11.Hrushesky WJ, Sothern RB, Du-Quiton J, Quiton DF, Rietveld W, Boon ME. Sunspot dynamics are reflected in human physiology and pathophysiology. Astrobiology 2011; 11: 93-103.

 

  1. 12.Kocken M, Baalbergen A, Snijders PJ, Bulten J, Quint WQ, Smedts F, Meijer CJ, Helmerhorst TJ. High-risk human papillomavirus seems not involved in DES-related and of limited importance in nonDES related clear-cell carcinoma of the cervix. Gynecol Oncol 2011; 122: 297-302.

 

  1. 13.de Koning MN, Khoe LV, Eekhof JA, Kamp M, Gussekloo J, ter Schegget J, Bouwes Bavinck J, Quint WG. Lesional HPV types of cutaneous warts can be reliably identified by surfasse swabs. J Clin Virol 2011; 52: 84-87.

 

  1. 14.de Koning MN, Polderman MC, Waterboer T, ter Schegget J, Feltkamp MC, Pawlita M, Bouwes Bavinck JN, Quint WG. Marked differences in Betapapillomavirus DNA and antibody prevalence between patients with psoriasis and those with atopic dermatitis. Br J Dermatol 2011; 164: 771-775.

 

  1. 15.Koshiol J, Rotunno M, Gillison ML, van Doorn LJ, Chaturvedi AK, Tarantini L, Song H, Quint WG, Struijk L, Goldstein AM, Hildesheim A, Taylor PR, Wacholder S, Bertazzi PA, Landi MT, Caporaso NE. Assessment of human papillomavirus in lung tumor tissue. J Natl Cancer Inst. 2011; 103: 501-507.

 

  1. 16.Kreimer AR, González P, Katki HA, Porras C, Schiffman M, Rodriguez AC, Solomon D, Jiménez S, Schiller JT, Lowy DR, van Doorn LJ, Struijk L, Quint W, Chen S, Wacholder S, Hildesheim A, Herrero R; CVT Vaccine Group. Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial. Lancet Oncol 2011; 12: 862-870.

 

  1. 17.Kreimer AR, Rodriguez AC, Hildesheim A, Herrero R, Porras C, Schiffman M, González P, Solomon D, Jiménez S, Schiller JT, Lowy DR, Quint W, Sherman ME, Schussler J, Wacholder S; CVT Vaccine Group. Proof-of-Principle evaluation of the efficacy of fewer than three doses of a bivalent HPV16/18 vaccine. J Natl Cancer Inst 2011; 103: 1444-1451.

 

  1. 18.Odida M, Sandin M, Mirembe F, Kleter B, Quint W, Weiderpass E. HPV types, HIV and invasive cervical carcinoma risk in Kampala, Uganda: a case-control study. Infect Agent Cancer 2011; 6: 8.

 

  1. 19.Proby CM, Harwoord CA, Neale RE, Euvrard S, Naldi L, Tessari G, Feltkamp MC, de Koning MN, Quint WG, Waterboer T, Pawlita M, Weissenborn S, Wieland U, Pfister H, Stockfleth E, Nindl I, Abeni D, ter Schegget JT, Bouwes Bavinck JN; EPI-HPV-CA-Group. A case-control study of betapapillomavirus infections and cutaneous squamous cell carcinoma in organ transplant recipients. Am J Transplant 2011; 11: 1498-1508.

 

  1. 20.Quint KD, Bom RJ, Quint WG, Bruisten SM, van der Loeff MF, Morré SA, de Vries HJ. Anal infections with concomitant Chlamydia trachomatis genotypes among men who have sex with men in Amsterdam, the Netherlands. BMC Infect Dis 2011; 11: 63.

 

  1. 21.Quint KD, Geraets DT, van den Munckhof HA, de Koning MN, Smelov V, Melchers WJ, de Vries HJ, Morré SA, Meijer CJ, van Alewijk DC, van Doorn LJ, Quint WQ. Evaluation of a novel Chlamydia trachomatis microsphere suspension assay for detection and genotyping of the different serovars in clinical samples. J Clin Virol 2011; 13: 152-159.

 

  1. 22.Quint W, Jenkins D, Molijn A, Struijk L, van de Sandt M, Doorbar J, Mols J, Van Hoof C, Hardt K, Struyf F, Colau B. One virus one lesion – Individual componentes of CIN lesions contain a specific HPV type. J Pathol 2011; 227: 62-71

 

  1. 23.Risse EKJ, Holierhoek JP, Meijer-Marres EM, Ouwerkerk-Noordam E, Boon ME. Increased diagnostic accurary of atypical glandular cells in cervical liquid-based cytology using cell blocks. Cytopathology 2011; 22: 253-260.

 

  1. 24.Risse EKJ, Ouwerkerk-Noordam E, Boon ME. Endometrial cells in liquid-based cervical cytology: a diagnostic pitfall solved by preparing cytohistology from the residual thin layer sample. Acta Cytol 2011; 55: 327-333.

 

  1. 25.Roteli-Martins CM, de Carvalho NS, Naud P, Teixeira J, Borba P, Derchain S, Tyring S, Gall S, Diaz A, Blatter M, Shier RM, Romanowski B, Quint WG, Issam J, Galindo C, Schuind A, Dubin G. Prevalence of human papillomavirus infection and associated risk factors in young women in Brazil, Canada, and the United States: a multicenter cross-sectional study. Int J Gynecol Pathol 2011; 30: 173-184.

 

  1. 26.Sanchez GI, Kleter B, Gheit T, van Doorn LJ, de Koning MN, de Sanjosé S, Alemany L, Bosch XF, Tommasino M, Muñoz N, Quint WG. Clinical evaluation of polymerase chain reaction reverse hybridization assay for detection and identification of human papillomavirus type 16 variants. J Clin Virol 2011; 51: 165-169.

 

  1. 27.Schmeink CE, Melchers WJ, Siebers AG, Quint WG, Massuger LF, Bekkers RL. Human papillomavirus persistence in young unscreened women, a prospective cohort study. PLoS One 2011; 6: e27937.

 

  1. 28.Schmitt M, de Koning MN, Eekhof JÁ, Quint WG, Pawlita M. Evaluation of a novel multiplex human papillomavirus (HPV) genotyping assay for HPV types in skin warts. J Clin Microbiol 2011; 49: 3262-3267.

 

  1. 29.Sethi S, Ali-Fehmi R, Franceschi S, Struijk L, van Doorn LJ, Quint W, Albashiti B, Ibrahim M, Kato I. Characteristics and survival of head and neck cancer by HPV status: a cancer registry-based study. Int J Cancer 2012; 131: 1179-1186.

 

  1. 30.Tabora N, Bulnes R, Toro LA, Claros JM, Massuger LF, Quint WG, Melchers WJ, Ferrera A. Human papillomavirus infection in Honduran women with cervical intraepithelial neoplasia or cervical cancer. J Low Genit Tract Dis 2011; 15: 48-53.

 

  1. 31.Terlou A, van Seters M, Ewing PC, Aaronson NK, Gundy CM, Heijmans-Antonissen C, Quint WQ, Blok LJ, van Beurden M, Helmerhorst TJ. Treatment of vulvar intraepithelial neoplasia with topical imiquimod: seven years median follow-up of a randomized clinical trial. Gynecol Oncol 2011; 121: 157-162.

 

2012

  1. 1.Alemany L, Pérez C, Tous S, Llombart-Bosch A, Lloveras B, Lerma E, Guarch R, Andujar M, Pelayo A, Alejo M, Ordi J, Klaustermeier J, Velasco J, Guimerà N, Clavero O, Castellsagué X, Quint W, Munoz N, Bosch FX, de Sanjosé S. Human papillomavirus genotype distribution in cervical cancer cases in Spain. Implications for prevention. Gynecol Oncol 2012; 124: 512-517.

 

  1. 2.van Baars R, Bosgraaf RP, ter Harmsel BW, Melchers WJ, Quint WG, Bekkers RL. Dry storage and transport of a cervicovaginal self-sample by use of the evalyn brush, providing reliable human papillomavirus detection combined with comfort for women. J Clin Microbiol 2012; 50: 3937-3943.

 

  1. 3.Benschop CC, Quaak FC, Boon ME, Sijen T, Kuiper I. Vaginal microbial flora analysis by next generation sequencing and microarrays; can microbes indicate vaginal origin in a forensic context? Int J Legal Med 2012; 126: 303-310.

 

  1. 4.Boon ME, Dols JAM, Butamanya N, Reid G. The Cellient system for cytohistology to analyze p16 positive dyskeratocytes in paraffin sections of HPV-positive cervical scrapes. J Anal Oncol 2012; 1: 88-94.

 

  1. 5.Boon ME, Holloway PA, Breijer H, Bontekoe TjR. Gardnerella, Trichomonas, and Candida in cervical smears of 58,904 immigrants participating in the Dutch national cervical screening program. Acta Cytol 2012; 56: 242-246.

 

  1. 6.Boon ME, Kok LP. Fixative composition. Chinese Patent (op BoonFix) No. ZL 200580026963.8. 8 augustus 2012.

 

  1. 7.Bruggink SC, de Koning MN, Gussekloo J, Egberts PF, ter Schegget J, Feltkamp MC, Bavinck JN, Quint WG, Assendelft WJ, Eekhof JA. Cutaneous wart-associated HPV types: prevalence and relation with patient characteristics. J Clin Virol 2012; 55: 250-255.

 

  1. 8.Castro FA, Quint W, Gonzalez P, Katki HÁ, Herrero R, van Doorn LJ, Schiffman M, Struijk L, Rodriguez AC, Delvecchio C, Lowy DR, Porras C, Jimenez S, Schiller J, Solomon D, Wacholder S, Hildesheim A, Kreimer AR; for the Costa Rica Vaccine Trial Group. Prevalence of and risk factos for anal human papillomavirus infection among young healthy women in Costa Rica. J Infect Dis 2012; 206: 1103-1110.

 

  1. 9.Cubilla AL, Lloveras B, Alemany L, Alejo M, Vidal A, Kasamatsu E, Clavero O, Alvarado-Cabrero I, Lynch C, Velasco-Alonso J, Ferrera A, Chaux A, Klaustermeier J, Quint W, de Sanjosé S, Muñoz N, Bosch FX. Basaloid squamous cell carcinoma of the pénis with papillary features: a clinicopathologic study of 12 cases. Am J Surg Pathol 2012; 36: 869-875.

 

  1. 10.Del Pino M, Bleeker MC, Quint WQ, Snijders P, Meijer CJ, Steenbergen RD. Comprehensive analysis of human papillomavirus prevalence and the potential role of low-risk types in verrucous carcinoma. Mol Pathol 2012; 25: 1354-1363.

 

  1. 11.Dols JA, Reid G, Brown JM, Tempelman H, Bontekoe TR, Quint WG, Boon ME. HPV type distribution and cervical cytology among HIV-positive Tanzanian and South African women. ISRN Obstet Gynecol 2012; 2012: 514146.

 

  1. 12.Dols JAM, Boon ME. An in vitro study of the effects of self care gels on desirable and undesirable vaginal microbiota. Eur Obstet Gynecol 2012; 107-110.

 

  1. 13.Dols JAM, Reid G, Brown JM, Tempelman H, Bontekoe TjR,Quint W, Boon ME. HPV type distribution and cervical cytology among HIV-positive African women. ISRN Obstet Gynecol 2012; 2012: 514146.

 

  1. 14.Dols JAM, Reid G, Kort R, Schuren FHJ, Tempelman H, Bontekoe TjR, Korporaal H, van der Veer EM, Smit PW, Boon ME. PCR-based identification of eight Lactobacillus species and 18 hr-HPV genotypes in fixed cervical samples of South African women at risk of HIV and BV. Diagn Cytopathol 2012; 40: 472-477. 2011.

 

  1. 15.Geraets D, Alemany L, Guimera N, de Sanjose S, de Koning M, Molijn A, Jenkins D, Bosch X, Quint W; on behalf of the RIS HPV TT study group. Detection of rare and possibly carcinogenic human papillomavirus genotypes as single infections in invasive cervical cancer. J Pathol 2012 (Epub ahead of print).

 

  1. 16.Kasamatsu E, Cubilla AL, Alemany L, Chaux A, Tous S, Mendoza L, Paez M, Klaustermeier JE, Quint W, Lloveras B, de Sanjose S, Muñoz N, Bosch FX. Type-specific human papillomavirus distribution in invasive cervical carcinomas in Paraguay. A study of 432 cases. J Med Virol 2012; 84: 1628-1635.

 

  1. 17.Lehtinen M, Paavonen J, Wheeler CM, Jaisamrarn U, Garland SM, Castellsagué X, Skinner SR, Apter D, Naud P, Salmerón J, Chow SN, Kitchener H, Teixeira JC, Hedrick J, Limson G, Szareski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, De Carvalho NS, Germar MJ, Peters K, Mindel A, De Sutter P, Bosch FX, David MP, Descamps D, Struyf F, Dubin G; HPV PATRICIA Study Group. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol 2012; 13: 89-99.

 

  1. 18.Lowe SW, Katsidzira L, Meys R, Sterling JC, de Koning M, Quint W, Nathoo K, Munyati S, Ndhlovu CE, Salisbury JR, Bunker CB, Corbett EL, Miller RF, Ferrand RA. Acquired epidermodysplasia verruciformis due to multiple and unusual HPV infection among vertically-infected, HIV-positive adolescentes in Zimbabwe. Clin Infect Dis 2012; 54: 119-123.

 

  1. 19.van der Marel J, Quint W, Smedts F, Jenkins D, Verheijen R, Helmerhorst T. Changing human papillomavirus genotype attribution in squamous preneoplastic lesions studied by laser capture microscopy-polymerase chain reaction in a diethylstilbestrol-exposed woman during 8 years of follow-up. Histopathology 2012; 61: 987-989.

 

  1. 20.van der Marel J, Quint WQ, Schiffman M, van de Sandt MM, Zuna RE, Terence Dunn S, Smith K, Mathews CA, Gold MA, Walker J, Wentzensen N. Molecular mapping of high-grade cervical intraepithelial neoplasia shows etiological dominance of HPV16. Int J Cancer 2012; 131: 946-953.

 

  1. 21.Meeuwis KA, Melchers WJ, Bouten H, van de Kerkhof PC, Hinten F, Quint WQ, Massuger LF, Hoitsma AJ, van Rossum MM, de Hullu JÁ. Anogenital malignancies in women after renal transplantation over 40 years in single center. Transplantation 2012; 93: 914-922.
  2. 22.Roeters AME, Boon ME, van Haaften M, Vernooij F, Bontekoe TjR, Heintz APM. Papanicolaou’s nebular cells are related to HPV infection and HSIL. Diagn Cytopathol 2012; 40: 197-200.

 

  1. 23.Safaeian M, Ghosh A, Porras C, Lin SW, Rodriguez AC, Schiffman M, Wacholder S, Kemp T, Gonzalez P, Wentzensen N, Esser M, Meuree A, Matys K, Quint W, van Doorn LJ, Sherman ME, Herrero R, Pinto LA, Hildesheim A. Direct comparison of HPV16 serological assays used to define HPV-naive women in HPV Vaccine Trials. Cancer Epidemiol Biomarkers Prev 2012; 21: 1547-1554.

 

  1. 24.Sampogna F, Bouwes Bavinck JN, Pawlita M, Abeni D, Harwood C, Proby C, Feltkamp M, Euvrard S, Naldi L, Neale R, Nindl L, Pfister H, Quint W, Waterboer T. Factors associated with the seroprevalence of 26 cutaneous and two genital human papillomavirus types in organ transplant patients. J Gen Virol 2012; 93: 165-174.

 

  1. 25.Sanchez GI, Jaramillo R, Cuello G, Quintero K, Baena A, O’Byrne A, Reyes AJ, Santamaria C, Cuello H, Arrunategui A, Cortez A, Osorio G, Reina JC, Quint WG, Muñoz N. Human papillomavirus genotype detection in recurrent respiratory papillomatosis (RRP) in Colombia. Head Neck 2012; 35: 229-234.

 

  1. 26.Sethi S, Ali-Fehmi R, Franceschi S, Struijk L, van Doorn LJ, Quint W, Albashiti B, Ibrahim M, Kato I. Characteristics and survival of head and neck cancer by HPV status: a cancer registry-based study. Int J Cancer 2012; 131: 1179-1186.

 

  1. 27.Szarewski A, Poppe WA, Skinner SR, Wheeler CM, Paavonen J, Naud P, Salmeron J, Chow SN, Apter D, Kitchener H, Castellsagué X, Teixeira JC, Hedrick J, Jaisamrarn U, Limson G, Garland S, Romanowski B, Aoki FY, Schwarz TF, Bosch FX, Harper DM, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G: HPV PATRICIA Study Group. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol 2012; 13: 100-110.

 

  1. 28.Tjalma WA, Fiander A, Reich O, Powell N, Nowakowski AM, Kirschner B, Koiss R, O'Leary J, Joura EA, Rosenlund M, Colau B, Schledermann D, Kukk K, Damaskou V, Repanti M, Vladareanu R, Kolomiets L, Savicheva A, Shipitsyna E, Ordi J, Molijn A, Quint W, Raillard A, Rosillon D, De Souza SC, Jenkins D, Holl K; HERACLES/SCALE Study Group. Differences in human papillomavirus type distribution in high-grade cervical intraepithelial neoplasia and invasive cervical cancer in Europe. Int J Cancer 2013; 132: 854-867.

 

  1. 29.Weissenborn S, Neale RE, Waterboer T, Abeni D, Bavinck JN, Green AC, Harwood CA, Euvrard S, Feltkamp MC, de Koning MN, Naldi L, Quint WG, Tessari G, Proby CM, Wieland U, Pfister H; EPI-HPV-UV-CA group. Beta-papillomavirus DNA loads in hair follicles of immunocompetent people and organ transplant recipients. Med Microbiol Immunol 2012; 201: 117-125.

 

  1. 30.Wheeler CM, Castellsagué X, Garland SM, Szarewski A, Paavonen J, Naud P, Salmerón J, Chow SN, Apter D, Kitchener H, Teixeira JC, Skinner SR, Jaisamrarn U, Limson G, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Harper DM, Huh W, Hardt K, Zahaf T, Descamps D, Struyf F, Dubin G, Lethinen M; HPV PATRICIA Study Group. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial. Lancet Oncol 2012; 13: 100-110.

 

 

Heeft u een vraag?